|
Ramantamig Clinical Trials
3 actively recruiting trials across 2 locations
▲ +1 trial since September 2026
Also known as: BCMAxGPRC5DxCD3, JNJ-79635322
Pipeline
Phase 2: 2Phase 3: 1
Top Sponsors
- Janssen Research & Development, LLC3
Indications
- Multiple Myeloma3
- Cancer3
- Relapse Multiple Myeloma1
- Refractory Multiple Myeloma1
Other1 trial
Goodyear, Arizona1 trial
San Francisco, California1 trial
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
University of California San Francisco
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.